FHL2 and neoplasm: This signature includes LDHA, NSDHL, TP53INP2, FLT1, IRS1, ELOVL7, AGPS, FHL2, MED6, PLIN3, VDAC1, and SULT2B1, most of which were revealed to be correlated with tumor proliferation and progression (39–47).